1. The effect of hypoxia on photodynamic therapy with 5-aminolevulinic acid in malignant gliomas
- Author
-
Tomohiro Ihata, Naosuke Nonoguchi, Takahiro Fujishiro, Naoki Omura, Shinji Kawabata, Yoshinaga Kajimoto, and Masahiko Wanibuchi
- Subjects
History ,Photosensitizing Agents ,Polymers and Plastics ,Biophysics ,Protoporphyrins ,Dermatology ,Aminolevulinic Acid ,Glioma ,Industrial and Manufacturing Engineering ,Oxygen ,Oncology ,Photochemotherapy ,Cell Line, Tumor ,Tumor Microenvironment ,Humans ,Pharmacology (medical) ,Business and International Management ,Hypoxia - Abstract
Glioblastoma (GBM) is a high-grade, poor prognosis tumor that is resistant to standard treatment. The presence of a small number of glioma stem cells (GSCs) surviving in the harsh microenvironment is responsible for their refractoriness. This study aimed to investigate the effect of a hypoxic environment on the sensitivity of GSCs to photodynamic therapy with 5-aminolevulinic acid (ALA-PDT).Six human GSC lines, Mesenchymal types HGG13, HGG30, HGG1123, and Proneural types HGG146, HGG157, HGG528, were divided into two groups: normoxia (OHypoxia-GSCs showed higher mRNA levels of FECH (ferrochelatase), which is required for iron synthesis to convert PpⅨ to heme, compared with Normoxia-GSCs. Flow cytometry revealed that the accumulation of PpⅨ in Hypoxia-GSCs reduced upon incubation with ALA. However, Hypoxia-GSCs showed less reduction in sensitivity to ALA-PDT than Normoxia-GSCs.Hypoxia-GSCs had lower intracellular PpⅨ accumulation than Normoxia-GSCs due to increased gene expression of FECH, and that their sensitivity to ALA-PDT was reduced less, despite accumulating lower concentrations of PpⅨ. ALA-PDT is a potentially effective therapy for hypoxia-tolerant GSCs that exist in hypoxia at 5% oxygen concentration.
- Published
- 2022